40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Lower upside than AR's upside of 54.83%.
Buy
Equal to AR's analyst recommendation of Buy.
Analyze analyst forecasts for the company and compare them with competitors.
9.86B
No previous data to compare.
4.89B
No previous data to compare.
7.39
No previous data to compare.
2.34B
No previous data to compare.
2.25B
No previous data to compare.
692.40M
No previous data to compare.
Analyze DCF forecasts for the company and compare them with competitors.
12.46B
Revenue has increased from the previous period.
43.96%
Revenue growth rate has increased from the previous period.
5.00B
EBITDA has increased from the previous period.
40.13%
EBITDA margin has increased from the previous period.
3.87B
EBIT has increased from the previous period.
31.06%
EBIT margin has increased from the previous period.
1.13B
Depreciation has decreased from the previous period.
5.00M
Total cash has decreased from the previous period.
0.04%
Cash percentage has decreased from the previous period.
1.53B
Receivables have increased from the previous period.
12.27%
Receivables percentage has decreased from the previous period.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
436.00M
Accounts payable has increased from the previous period.
3.50%
Payables percentage has decreased from the previous period.
-1.83B
Capital expenditure has increased from the previous period.
-14.69%
CapEx percentage has decreased from the previous period.
12.25%
WACC is unchanged from the previous period.
16.87%
Cost of equity is unchanged from the previous period.
5.31%
Cost of debt is unchanged from the previous period.
2.64
Beta is unchanged from the previous period.
263.90M
Diluted shares outstanding is unchanged from the previous period.
6.68B
Total debt is unchanged from the previous period.
10.03B
Total equity is unchanged from the previous period.
16.71B
Total capital is unchanged from the previous period.
39.98%
Debt weighting is unchanged from the previous period.
60.02%
Equity weighting is unchanged from the previous period.
3.95B
EBIAT has increased from the previous period.
3.14B
UFCF has increased from the previous period.
0.50%
Long-term growth rate is unchanged from the previous period.
-12.22B
Terminal value is unchanged from the previous period.
-10.85B
Enterprise value is unchanged from the previous period.
6.68B
Net debt is unchanged from the previous period.
-17.53B
Equity value is unchanged from the previous period.
-66.42
Equity value per share is unchanged from the previous period.
